1Rego EM,Pandolfi PP.Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models.Semin Hematol,2001,38(1):54-70.
2Lo-Coco F,Ammatuna E.The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment.Hematology,2006:156-61,514.
3Lionel Adès,Sylvie Chevret,Rafoux E,et al.Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European acute promyelocytic leukemia Group.J Clin Oncol,2006,24(36):5703-10.
5Yamazaki K,Terada H,Satoh H,et al.Arrhythmogenic Effects of Arsenic Trioxide in Patients With Acute Promyelocytic Leukemia and an Electrophysiological Study in Isolated Guinea Pig Papillary Muscles.Circ J,2006,70(11):1407-14.
6Pan XY,Chen GQ,Cai L,et al.Anion exchanger 2 mediates the action of arsenic trioxide.Br J Haematol.2006,134(5):491-9.
7Bernardini S,Nuccetelli M,Noguera NI,et al.Role of GSTP1-1 in mediating the effect of As2O3 in the acute promyelocytic leukemia cell line NB4.Ann Hematol,2006,85(10):681-7.
8Shen ZX,Shi ZZ,Fang J,et al.All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.Proc Natl Acad Sci USA,2004,101(15):5328-35.
9ZhenYi Wang and Zhu Chen.Acute promyelocytic leukemia:from highly fatal to highly curable.Blood,2008,111(5):2505-15.
10Lococo F,Cimino G,Breccia M,et al.Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia.Blood,2004,104(7):1995-9.
5POWELL B L.Effect of consolidation with arsenic trioxide (As2O3) on event-free survival (EFS) and overall survival (OS) among patients with newly diagnosed acute promyeloeytic leukemia (APL):North American Intergroup Protocol C9710[J].Proc Am Soc Clin Oncol,2007,25:2-2.
6LI X,SUN W J.A survival study and prognostic factors on acute promyelocytic leukemia at a single center[J].Leuk Res,2007,31:765-771.
7TALLMAN M S,BRENNER B,DE LA SERNA J,et al.Acute promyelocytic leukemia coagulopathy[J].Leuk Res,2005,29:347-351.
8SANZ M,MARTIN G,GONZALEZ M,et al.Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochem otherapy:a multicenter study by the PETHEMA group[J].Blood,2004,103:1237-1243.
9LO-COCO F,AVVISATI G,VIGNETTI M,et al.Frontline treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation:results of the AIDA-2000 trial of the Italian GIMEMA group[J].Blood,2004,104:392a.
10NAGAI S,ASAI T,WATANABE T,et al.Simultaneous appearance of central nervous system relapse and subarachnoid hemorrhage during the treatment for acute promyelocytic leukemia[J].Ann Hematol,2008,87:593-595.
